# SLC35F4

## Overview
SLC35F4 is a gene that encodes the protein solute carrier family 35 member F4, which is part of the solute carrier family involved in the transport of nucleotide sugars across cellular membranes. This protein is categorized as a putative nucleotide sugar transporter and is implicated in glycosylation pathways, essential for various cellular signaling processes. SLC35F4 is notably expressed in the adult cerebellum, indicating a potential role in brain function and development (Nishimura2009TissueSpecific). The expression of SLC35F4 is not uniform across all tissues, as it is absent in certain cell lines, suggesting tissue-specific roles and regulatory mechanisms (Smagin2021Reduced). Further research is needed to elucidate the precise molecular functions and clinical significance of SLC35F4.

## Function
SLC35F4 is a member of the solute carrier family 35, which is involved in the transport of nucleotide sugars across cellular membranes. This protein is thought to play a role in glycosylation pathways, which are critical for various cellular signaling processes. In healthy human cells, SLC35F4 is expressed at the highest levels in the adult cerebellum, suggesting a significant role in brain function (Nishimura2009TissueSpecific). The specific molecular function of SLC35F4 in human cells is not fully detailed, but it is categorized as a putative nucleotide sugar transporter, indicating its involvement in the transport of nucleotide sugars necessary for glycosylation (Smagin2021Reduced).

The expression of SLC35F4 is not ubiquitous across all cell types, as it is not consistently found in certain human cell lines like HeLa, Hep G2, and MDA 435, which suggests variability in its activity depending on the tissue or cell type (Nishimura2009TissueSpecific). This variability in expression may influence the protein's activity and its impact on cellular processes, particularly in tissues where it is highly expressed, such as the cerebellum. The precise role of SLC35F4 in these processes remains an area for further research.


## References


[1. (Smagin2021Reduced) Dmitry A. Smagin, Vladimir N. Babenko, Olga E. Redina, Irina L. Kovalenko, Anna G. Galyamina, and Natalia N. Kudryavtseva. Reduced expression of slc genes in the vta and nacc of male mice with positive fighting experience. Genes, 12(7):1099, July 2021. URL: http://dx.doi.org/10.3390/genes12071099, doi:10.3390/genes12071099. This article has 6 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/genes12071099)

[2. (Nishimura2009TissueSpecific) Masuhiro Nishimura, Satoshi Suzuki, Tetsuo Satoh, and Shinsaku Naito. Tissue-specific mrna expression profiles of human solute carrier 35 transporters. Drug Metabolism and Pharmacokinetics, 24(1):91â€“99, 2009. URL: http://dx.doi.org/10.2133/DMPK.24.91, doi:10.2133/dmpk.24.91. This article has 71 citations and is from a peer-reviewed journal.](https://doi.org/10.2133/DMPK.24.91)